« POPE 5 Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next

GSK and 23andMe sign agreement to leverage genetic insights for the development of novel medicines 

By: Riana in POPE 5 | Recommend this post (2)
Sun, 13 Jan 19 6:46 AM | 51 view(s)
Boardmark this board | Pope 5
Msg. 20145 of 62138
Jump:
Jump to board:
Jump to msg. #

And people wonder why I, as a genealogist, refuse to participate in any of the genealogy DNA projects.

What could possibly go wrong...

GSK and 23andMe today unveiled an exclusive four-year collaboration that will focus on research and development of innovative new medicines and potential cures, using human genetics as the basis for discovery. The collaboration will combine 23andMe’s large-scale genetic resources and advanced data science skills, with the scientific and medical knowledge and commercialisation expertise of GSK. The goal of the collaboration is to gather insights and discover novel drug targets driving disease progression and develop therapies for serious unmet medical needs based on those discoveries.

http://www.gsk.com/en-gb/media/press-releases/gsk-and-23andme-sign-agreement-to-leverage-genetic-insights-for-the-development-of-novel-medicines




Avatar

What is the point of rules that are not enforced?


- - - - -
View Replies (1) »



» You can also:
« POPE 5 Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next